Effect of Kava on Anxiety and Stress in Cancer Survivors

Clinical trial NCT06213298 · SUSPENDED

Trial details

NCT number: NCT06213298
Sponsor: Masonic Cancer Center, University of Minnesota
Status: SUSPENDED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Kava Anxiety Stress Cancer Depression Sleep

Start date: 2024-06-20
Primary completion: 2027-11-30
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.